Based on several claims on the positive effect of spirulina migroalgae in the treatment of male infertility, this study is aimed to assess the effect of spirulina microalgae on semen parameters in men with idiopathic infertility. Inclusion criteria included idiopathic infertility (abnormal sperm motility and morphology based on WHO index), evidence of wife fertility, and age 20-40 year. The patients with medical situation or surgery that can cause infertility, previous history of chemotherapy, history of varicocel of cryptorchidism, body mass index 30kg/m2 or greater, alcohol, drugs or other substance abuse, history of androgen or anti-androgen drugs consumption, severe kidney insufficiency (serum creatinine greater than 2.0 mg/dl), sever liver insufficiency (serum bilirubin greater than 2.0 mg/dl), azoospermia, and immune-suppressant drugs usage were excluded. Forty males with idiopathic infertility will be randomly assigned into two groups. The intervention group will receive 2g spirulina plus standard therapy for indiopathic infertility (L-carnitine, zinc sulfate, and 50mg/day clomiphene) for 3 months whereas the control group will just receive the standard regimen for 3 months. Sperm motility, morphology, and count will be assessed at baseline and 3 months later as a primary outcome. Only analysts are blinded in this study